1Andre T,Bensmaine M, Louvet C, et al. Multicenter phase Ⅱstudy of bimonthly high-dose leucovorin, fluorouracil infusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen[J].J Clin Oncol, 1999,17:3560-3568.
2Wilson RH, Lehky T, Thomas RR, et al.Acute oxaliplatin-induced peripheral nerve hyperexcitability[J].J Clin Oncol, 2002,20:1767-1774.
3Lehky TJ, Leonard GD, Wilson RH, et al. Oxaliplatin-induced neurotoxicity: acute hyperexcitability and chronic neuropathy[J]. Muscle Nerve, 2004,29(3):387-392.
4Grolleau F,Gamelin L, Boisdron-Celle M, et al.A possible explanation for a neurotoxic effect of the anticancer agent oxaliplatin on neuronal voltage-gated sodium channels[J]. J Neurophysiol, 2001,85:2293-2297.
5Lersch C, Schmelz R, Eckel F, et al. Prevention of oxaliplatin-induced peripheral sensory neuropathy by carbamazepine in patients with advanced colorectal cancer[J]. Clin Colorectal Cancer, 2002,2:54-58.
6Gamelin L,Boisdron-Celle M, Delva R, et al. Prevention of oxaliplatin-related neurotoxicity by calcium and magnesium infusions: a retrospective study of 161 patients receiving oxaliplatin combined with 5-Fluorouracil and leucovorin for advanced colorectal cancer[J].Clin Cancer Res, 2004,10(12 Pt 1):4055-4061.
7Cascinu S,Catalano V,Cordella L, et al.Neuroprotective effect of reduced glutathione on oxaliplatin-based chemotherapy in advanced colorectal cancer. A randomized, double-blind, placebo-controlled trial[J]. J Clin Oncol,2002,20:3478-3483
5Sargent DJ.Clinical predictors of recurrence site after hepatectomy for metastasic colorectal cancer[J].Hepatogastroenterology,2010,28(20):3219-3226.
6Gonzalez M,Robert JH,Halkic N,et al.Survival after lung metastasectomy in colorectal cancer patients with previously resected liver metastases[J].World J Surg,2012,36(2):386-391.
7Price TJ,Townsend AR,Beeke C,et al."Watchful waiting"for metastatic clolorectal cancer,antediluvian or an option to be considered again[J].Asia Pac J Clin Oncol,2012,8(11):10-13.
8Comella P.Optimizing the management of metastatis colorectal cancer[J].Crit Rev Oncol/Hematol,2010,75:15-26.
